Roles of mitogen-activated protein kinases and angiotensin II in renal development

Brazilian Journal of Medical and Biological Research

Volumn 42, Issue 1, 2009, Pages 38-43

  Balbi, A P C ^a   Francescato, H D C ^a   Marin, E C S ^a   Costa, R S ^a   Coimbra, T M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Angiotensin II; Angiotensin II antagonists; Mitogen activated protein kinase; Renal development; Sodium intake

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE;

ALBUMINURIA; APOPTOSIS; AUTOSOMAL RECESSIVE DISORDER; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CONFERENCE PAPER; EMBRYO DEVELOPMENT; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE CONTROL; GENE MUTATION; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; HIGH SODIUM INTAKE; HUMAN; KIDNEY CELL; KIDNEY DEVELOPMENT; KIDNEY DISEASE; KIDNEY TUBULE DISORDER; NONHUMAN; PROGENY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANIMALIA; MUS; RATTUS;

EID: 62749114747     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2009000100007     Document Type: Conference Paper

References (40)

1. Nigam SK, Aperia AC, Brenner BM. Development and maturation of the kidney. In: Brenner BM, Rector FC (Editors), The kidney: physiology and pathology. 5th edn. Philadelphia: WB Saunders; 1996. p 72-98.
2. Reeves W, Caulfield JP, Farquhar MG. Differentiation of epithelial foot processes and filtration slits: sequential appearance of occluding junctions, epithelial polyanion, and slit membranes in developing glomeruli. Lab Invest 1978; 39: 90-100.
3. Balbi AP, Costa RS, Coimbra TM. Postnatal renal development of rats from mothers that received increased sodium intake. Pediatr Nephrol 2004; 19: 1212-1218.
4. Roberts AB, McCune BK, Sporn MB. TGF-beta: regulation of extracellular matrix. Kidney Int 1992; 41: 557-559.
5. Thiery JP, Duband JL, Dufour S, Savagner P, Imhof BA. Role of fibronectins in embryogenesis. In: Mosher D (Editor), Biology of extracellular matrix: fibronectin. San Diego: Academic Press, Inc.; 1989. p 181-212.
6. Kagami S, Border WA, Miller DE, Noble NA. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest 1994; 93: 2431-2437.
7. Bagby SP, Holden W. Angiotensin II stimulates proliferation of aortic endothelial cells. Clin Res 1988; 36: 259A.
8. Carey AV, Carey RM, Gomez RA. Expression of alpha-smooth muscle actin in the developing kidney vasculature. Hypertension 1992; 19: II-168-II-175.
9. Naruse K, Fujieda M, Miyazaki E, Hayashi Y, Toi M, Fukui T, et al. An immunohistochemical study of developing glomeruli in human fetal kidneys. Kidney Int 2000; 57: 1836-1846.
10. Omori S, Hida M, Ishikura K, Kuramochi S, Awazu M. Expression of mitogen-activated protein kinase family in rat renal development. Kidney Int 2000; 58: 27-37.
11. Johnson RJ, Iida H, Alpers CE, Majesky MW, Schwartz SM, Pritzi P, et al. Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest 1991; 87: 847-858.
12. Bokemeyer D, Sorokin A, Dunn MJ. Multiple intracellular MAP kinase signaling cascades. Kidney Int 1996; 49: 1187-1198.
13. Balbi AP, Costa RC, Coimbra TM. Mitogen-activated protein kinases and angiotensin II expression in renal cortex of offspring from mothers submitted to increased salt intake. J Am Soc Nephrol 2004; 15: 416A (Abstract).
14. Kubo T, Ibusuki T, Chiba S, Kambe T, Fukumori R. Mitogen-activated protein kinase activity regulation role of angiotensin and endothelin systems in vascular smooth muscle cells. Eur J Pharmacol 2001; 411: 27-34.
15. Choi BM, Yoo KH, Bae IS, Oh MH, Hong YS, Lee JW, et al. Angiotensin-converting enzyme inhibition modulates mitogen-activated protein kinase family expressions in the neonatal rat kidney. Pediatr Res 2005; 57: 115-123.
16. Woolf AS, Winyard PJ. Advances in the cell biology and genetics of human kidney malformations. J Am Soc Nephrol 1998; 9: 1114-1125.
17. Gomez RA, Lynch KR, Sturgill BC, Elwood JP, Chevalier RL, Carey RM, et al. Distribution of renin mRNA and its protein in the developing kidney. Am J Physiol 1989; 257: F850-F858.
18. Gomez RA, Tufro-McReddie A, Everett AD, Pentz ES. Ontogeny of renin and AT1 receptor in the rat. Pediatr Nephrol 1993; 7: 635-638.
19. Millan MA, Carvallo P, Izumi S, Zemel S, Catt KJ, Aguilera G. Novel sites of expression of functional angiotensin II receptors in the late gestation fetus. Science 1989; 244: 1340-1342.
20. Tufro-McReddie A, Harrison JK, Everett AD, Gomez RA. Ontogeny of type 1 angiotensin II receptor gene expression in the rat. J Clin Invest 1993; 91: 530-537.
21. Grady EF, Sechi LA, Griffin CA, Schambelan M, Kalinyak JE. Expression of AT2 receptors in the developing rat fetus. J Clin Invest 1991; 88: 921-933.
22. Yosypiv IV, Schroeder M, El-Dahr SS. Angiotensin II type 1 receptor-EGF receptor cross-talk regulates ureteric bud branching morphogenesis. J Am Soc Nephrol 2006; 17: 1005-1014.
23. Gribouval O, Gonzales M, Neuhaus T, Aziza J, Bieth E, Laurent N, et al. Mutations in genes in the renin-angiotensin system are associated with autosomal recessive renal tubular dysgenesis. Nat Genet 2005; 37: 964-968.
24. Niimura F, Labosky PA, Kakuchi J, Okubo S, Yoshida H, Oikawa T, et al. Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation. J Clin Invest 1995; 96: 2947-2954.
25. Kumar D, Menon V, Ford WR, Clanachan AS, Jugdutt BI. Effect of angiotensin II type 2 receptor blockade on mitogen activated protein kinases during myocardial ischemia-reperfusion. Mol Cell Biochem 2004; 258: 211-218.
26. Yang D, Tournier C, Wysk M, Lu HT, Xu J, Davis RJ, et al. Targeted disruption of the MKK4 gene causes embryonic death, inhibition of c-Jun NH2-terminal kinase activation, and defects in AP-1 transcriptional activity. Proc Natl Acad Sci U S A 1997; 94: 3004-3009.
27. Hida M, Omori S, Awazu M. ERK and p38 MAP kinase are required for rat renal development. Kidney Int 2002; 61: 1252-1262.
28. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995; 270: 1326-1331.
29. Nicolantonio RD, Spargo S, Morgan TO. Prenatal high salt diet increases blood pressure and salt retention in the spontaneously hypertensive rat. Clin Exp Pharmacol Physiol 1987; 14: 233-235.
30. da Silva AA, de Noronha I, de Oliveira I, Malheiros DM, Heimann JC. Renin-angiotensin system function and blood pressure in adult rats after perinatal salt overload. Nutr Metab Cardiovasc Dis 2003; 13: 133-139.
31. Hazon N, Parker C, Leonard R, Henderson IW. Influence of an enriched dietary sodium chloride regime during gestation and suckling and post-natally on the ontogeny of hypertension in the rat. J Hypertens 1988; 6: 517-524.
32. Marin EC, Balbi AP, Francescato HD, Alves da Silva CG, Costa RS, Coimbra TM. Renal structure and function evaluation of rats from dams that received increased sodium intake during pregnancy and lactation submitted or not to 5/6 nephrectomy. Ren Fail 2008; 30: 547-555.
33. Daikha-Dahmane F, Levy-Beff E, Jugie M, Lenclen R. Foetal kidney maldevelopment in maternal use of angiotensin II type I receptor antagonists. Pediatr Nephrol 2006; 21: 729-732.
34. Spence SG, Zacchei AG, Lee LL, Baldwin CL, Berna RA, Mattson BA, et al. Toxicokinetic analysis of losartan during gestation and lactation in the rat. Teratology 1996; 53: 245-252.
35. Spence SG, Allen HL, Cukierski MA, Manson JM, Robertson RT, Eydelloth RS. Defining the susceptible period of developmental toxicity for the AT1-selective angiotensin II receptor antagonist losartan in rats. Teratology 1995; 51: 367-382.
36. Akil I, Inan S, Gurcu B, Nazikoglu A, Ozbilgin K, Muftuoglu S. Histopathological and ultrastructural effects of losartan on embryonic rat kidney. Acta Histochem 2005; 107: 291-300.
37. Friberg P, Sundelin B, Bohman SO, Bobik A, Nilsson H, Wickman A, et al. Renin-angiotensin system in neonatal rats: induction of a renal abnormality in response to ACE inhibition or angiotensin II antagonism. Kidney Int 1994; 45: 485-492.
38. Chen Y, Lasaitiene D, Gabrielsson BG, Carlsson LM, Billig H, Carlsson B, et al. Neonatal losartan treatment suppresses renal expression of molecules involved in cell-cell and cell-matrix interactions. J Am Soc Nephrol 2004; 15: 1232-1243.
39. Machado FG, Poppi EP, Fanelli C, Malheiros DM, Zatz R, Fujihara CK. AT1 blockade during lactation as a model of chronic nephropathy: mechanisms of renal injury. Am J Physiol Renal Physiol 2008; 294: F1345-F1353.
40. Balbi AP, Marin EC, Francescato HD, Costa RS, Coimbra TM. MAPK and angiotensin II receptor in kidney of newborn rats from losartan-treated dams. Pediatr Nephrol 2008; 23: 1433-1444.